학술논문
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: Rationale and design of the MESOPEC trial
Document Type
Article
Author
Source
In: BMJ Open . (BMJ Open, 1 May 2019, 9(5))
Subject
Language
English
ISSN
20446055